基因多态性与非小细胞肺癌：未来范式
Genetic polymorphisms and non-small-cell lung cancer: future paradigms.
作者信息
de Mello Ramon Andrade Bezerra
机构信息
Serviço de Oncologia Médica, Instituto Português de Oncologia Francisco Gentil, Porto, Portugal.
出版信息
Einstein (Sao Paulo). 2014 Oct-Dec;12(4):524-6. doi: 10.1590/S1679-45082014RB2906. Epub 2014 Nov 18.
Abstract
This article addresses some current issues about genetic polymorphisms studied in the non-small-cell lung cancer translational field. Furthermore, it discusses about new potential biomarkers regarding lung cancer risk and prognosis.
摘要
本文探讨了非小细胞肺癌转化领域中基因多态性研究的一些当前问题。此外，还讨论了关于肺癌风险和预后的新的潜在生物标志物。
相似文献
1
Genetic polymorphisms and non-small-cell lung cancer: future paradigms.基因多态性与非小细胞肺癌：未来范式
Einstein (Sao Paulo). 2014 Oct-Dec;12(4):524-6. doi: 10.1590/S1679-45082014RB2906. Epub 2014 Nov 18.
2
Vascular endothelial growth factor polymorphisms in early-stage non-small-cell lung cancer.早期非小细胞肺癌中的血管内皮生长因子多态性
J Clin Oncol. 2008 Jul 1;26(19):3289-90; author reply 3290. doi: 10.1200/JCO.2008.17.3880.
3
Genetic polymorphisms of the epidermal growth factor and related receptor in non-small cell lung cancer--a review of the literature.非小细胞肺癌中表皮生长因子及相关受体的基因多态性——文献综述
Oncologist. 2007 Feb;12(2):201-10. doi: 10.1634/theoncologist.12-2-201.
4
Epidermal growth factor receptor intron-1 polymorphism predicts gefitinib outcome in advanced non-small cell lung cancer.表皮生长因子受体内含子1多态性可预测晚期非小细胞肺癌患者对吉非替尼的治疗反应
J Thorac Oncol. 2008 Oct;3(10):1104-11. doi: 10.1097/JTO.0b013e3181861d67.
5
Non-small cell lung cancer--genetic predictors.非小细胞肺癌——基因预测指标
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2013 Jun;157(2):125-36. doi: 10.5507/bp.2013.034. Epub 2013 May 29.
6
[EML4-ALK fusion in non-small-cell lung cancer].
Zhonghua Jie He He Hu Xi Za Zhi. 2011 Mar;34(3):207-9. doi: 10.3760/cma.j.issn1001-0939.2011.03.016.
7
Vascular endothelial growth factor genotypes, haplotypes, gender, and the risk of non-small cell lung cancer.血管内皮生长因子基因型、单倍型、性别与非小细胞肺癌风险
Clin Cancer Res. 2008 Jan 15;14(2):612-7. doi: 10.1158/1078-0432.CCR-07-1655.
8
DNA repair gene X-ray repair cross complementing group 1 Arg194Trp polymorphism on the risk of lung cancer: a meta-analysis on 22 studies.X 射线修复交叉互补基因 1 精氨酸 194 色氨酸多态性与肺癌风险的关系：22 项研究的荟萃分析。
J Thorac Oncol. 2010 Nov;5(11):1741-7. doi: 10.1097/JTO.0b013e3181f0c409.
9
A three gene-based risk score predicts prognosis of resected non-small-cell lung cancer.一种基于三个基因的风险评分可预测切除的非小细胞肺癌的预后。
Int J Clin Exp Pathol. 2015 Dec 1;8(12):16081-8. eCollection 2015.
10
Vascular endothelial growth factor receptor 2 gene polymorphisms as predictors for tumor recurrence and overall survival in non-small-cell lung cancer.血管内皮生长因子受体 2 基因多态性作为非小细胞肺癌肿瘤复发和总生存的预测因子。
Ann Surg Oncol. 2012 Jul;19(7):2159-68. doi: 10.1245/s10434-012-2227-4. Epub 2012 Mar 7.
引用本文的文献
1
Immunotherapy for lung cancer: for whom the bell tolls?肺癌免疫疗法：钟声为谁而鸣？
Tumour Biol. 2015 Mar;36(3):1411-22. doi: 10.1007/s13277-015-3285-6. Epub 2015 Mar 4.
本文引用的文献
1
The impact of polymorphic variations in the 5p15, 6p12, 6p21 and 15q25 Loci on the risk and prognosis of portuguese patients with non-small cell lung cancer.5p15、6p12、6p21 和 15q25 位点多态性变异对葡萄牙非小细胞肺癌患者风险和预后的影响。
PLoS One. 2013 Sep 6;8(9):e72373. doi: 10.1371/journal.pone.0072373. eCollection 2013.
2
Anaplastic lymphoma kinase gene rearrangement and non-small cell lung cancer management: a step forward in personalized therapy.间变性淋巴瘤激酶基因重排与非小细胞肺癌的治疗：个性化治疗向前迈进的一步。
Clinics (Sao Paulo). 2013 May;68(5):726. doi: 10.6061/clinics/2013(05)24.
3
Results of initial low-dose computed tomographic screening for lung cancer.肺癌初始低剂量计算机断层扫描筛查结果。
N Engl J Med. 2013 May 23;368(21):1980-91. doi: 10.1056/NEJMoa1209120.
4
Back to EGF+61 genetic polymorphisms and lung cancer risk: looking to the future!回到表皮生长因子（EGF）+61基因多态性与肺癌风险：展望未来！
Sao Paulo Med J. 2012;130(6):415-6. doi: 10.1590/s1516-31802012000600011.
5
Activity and safety of crizotinib in patients with ALK-positive non-small-cell lung cancer: updated results from a phase 1 study.ALK 阳性非小细胞肺癌患者中克唑替尼的活性和安全性：来自一项 I 期研究的更新结果。
Lancet Oncol. 2012 Oct;13(10):1011-9. doi: 10.1016/S1470-2045(12)70344-3. Epub 2012 Sep 4.
6
Personalizing medicine: strategies for implementing the evaluation of anaplastic lymphoma kinase rearrangement in non-small-cell lung cancer in Portugal.个性化医疗：葡萄牙实施非小细胞肺癌间变性淋巴瘤激酶重排评估的策略
Rev Port Pneumol. 2012 Sep-Oct;18(5):244-6. doi: 10.1016/j.rppneu.2012.04.011. Epub 2012 Jun 29.
7
Association between EGF +61 genetic polymorphisms and non-small cell lung cancer increased risk in a Portuguese population: a case-control study.表皮生长因子（EGF）+61基因多态性与葡萄牙人群非小细胞肺癌风险增加之间的关联：一项病例对照研究。
Tumour Biol. 2012 Oct;33(5):1341-8. doi: 10.1007/s13277-012-0382-7. Epub 2012 Mar 29.
8
Cancer statistics, 2012.癌症统计数据，2012 年。
CA Cancer J Clin. 2012 Jan-Feb;62(1):10-29. doi: 10.3322/caac.20138. Epub 2012 Jan 4.
9
Vascular endothelial growth factor A gene (VEGFA) polymorphisms and expression of VEGFA gene in lung cancer patients of Kashmir Valley (India).克什米尔山谷（印度）肺癌患者血管内皮生长因子A基因（VEGFA）多态性及VEGFA基因表达情况
Tumour Biol. 2012 Jun;33(3):833-9. doi: 10.1007/s13277-011-0306-y. Epub 2012 Jan 10.
10
Epidermal growth factor receptor and K-Ras in non-small cell lung cancer-molecular pathways involved and targeted therapies.非小细胞肺癌中的表皮生长因子受体和K-Ras——相关分子途径及靶向治疗
World J Clin Oncol. 2011 Nov 10;2(11):367-76. doi: 10.5306/wjco.v2.i11.367.
Zotero 插件